Opening of Intermediate Conductance Ca2+-Activated K+ Channels in C2C12 Skeletal Muscle Cells Increases the Myotube Diameter via the Akt/Mammalian Target of Rapamycin Pathway-Reference-Cited by-同舟云学术

Opening of Intermediate Conductance Ca2+-Activated K+ Channels in C2C12 Skeletal Muscle Cells Increases the Myotube Diameter via the Akt/Mammalian Target of Rapamycin Pathway

Published:2020-12-29 Issue:3 Volume:376 Page:454-462
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Iseki Yuzo,Ono Yuko,Hibi Chihiro,Tanaka Shoko,Takeshita Shunya,Maejima Yuko,Kurokawa Junko,Murakawa Masahiro,Shimomura Kenju,Sakamoto Kazuho^ORCID

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference55 articles.

1. The potassium channels TASK2 and TREK1 regulate functional differentiation of murine skeletal muscle cells

2. Cardiac protection by mitoKATP channels is dependent on Akt translocation from cytosol to mitochondria during late preconditioning

3. During post-natal human myogenesis, normal myotube size requires TRPC1 and TRPC4 mediated Ca2+ entry

4. Human myoblast differentiation: Ca(2+) channels are activated by K(+) channels;Bernheim;News Physiol Sci,2002

5. T-type alpha 1H Ca2+ channels are involved in Ca2+ signaling during terminal differentiation (fusion) of human myoblasts

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiology of skeletal muscle during sepsis;Folia Pharmacologica Japonica;2024-03-01

2. Ca2+-Activated K+ Channels in Progenitor Cells of Musculoskeletal Tissues: A Narrative Review;International Journal of Molecular Sciences;2023-04-05

3. Role of organellar Ca2+-activated K+ channels in disease development;Life Sciences;2023-03

4. Kampo formula hochu-ekki-to (Bu-Zhong-Yi-Qi-Tang, TJ-41) ameliorates muscle atrophy by modulating atrogenes and AMPK in vivo and in vitro;BMC Complementary Medicine and Therapies;2022-12-28

5. KCa3.1 in diabetic kidney disease;Current Opinion in Nephrology & Hypertension;2021-10-27